Simultaneous Liver Transplant, Sleeve Gastrectomy Beneficial
By Elana Gotkine HealthDay Reporter
FRIDAY, May 9, 2025 -- Simultaneous liver transplant and sleeve gastrectomy (LTSG) yield durable weight loss, resolution of diabetes and hypertension, and a reduction in allograft steatosis development, according to a study recently published online in the Journal of Hepatology.
Ellen L. Larson, M.D., from the William Von Liebig Center for Transplantation at the Mayo Clinic College of Medicine Rochester in Minnesota, and colleagues conducted a retrospective cohort study involving 72 patients undergoing LTSG and 185 patients with body mass index (BMI) >30 kg/m2 who underwent LT alone for metabolic-associated steatotic liver disease.
The researchers observed no significant difference in mortality and graft loss for LT versus LTSG patients. A significantly lower prevalence of diabetes was seen for more than eight years for post-LTSG patients, while hypertension decreased from 61.1 to 38.5 percent. Compared with baseline, significant weight loss was seen for more than nine years for LTSG patients, with an average baseline BMI of 45.5 kg/m2. No significant change in BMI or diabetes was seen for LT patients, who had an average baseline BMI of 34.0 kg/m2. Allograft steatosis development was significantly lower in LTSG versus LT patients. The prevalence of fibrosis was reduced in LTSG versus LT patients at three to 10 years postoperatively, although the reduction was not significant.
"Given the rising obesity epidemic world-wide, it is essential to find solutions that provide increased transplant access and improved metabolic outcomes for this complex patient population," the authors write.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted May 2025
Read this next
Prevalence of Extremely Severe Obesity Increasing in Children
TUESDAY, July 22, 2025 -- From 2008 to 2023, there was an increase in the prevalence of extremely severe obesity in children, especially among older adolescents and non-Hispanic...
Long-Term Obesity Linked to Expression of Aging Biomarkers
THURSDAY, July 17, 2025 -- Long-term obesity is associated with the expression of biomarkers denoting antagonistic and integrative aging hallmarks in adults aged 28 to 31 years...
ENDO: Older Age, Female Sex Tied to Greater Muscle Loss With Semaglutide
THURSDAY, July 17, 2025 -- Older age and female sex may be associated with greater muscle loss in adults with obesity prescribed semaglutide, and greater muscle loss is...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.